112 related articles for article (PubMed ID: 16158060)
1. Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer.
Katuri V; Tang Y; Marshall B; Rashid A; Jogunoori W; Volpe EA; Sidawy AN; Evans S; Blay J; Gallicano GI; Premkumar Reddy E; Mishra L; Mishra B
Oncogene; 2005 Dec; 24(54):8012-24. PubMed ID: 16158060
[TBL] [Abstract][Full Text] [Related]
2. The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.
Mishra L; Katuri V; Evans S
Cancer Biol Ther; 2005 Jul; 4(7):694-9. PubMed ID: 16096365
[TBL] [Abstract][Full Text] [Related]
3. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
[TBL] [Abstract][Full Text] [Related]
4. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.
Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L
Cancer Res; 2005 May; 65(10):4228-37. PubMed ID: 15899814
[TBL] [Abstract][Full Text] [Related]
6. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice.
Tang Y; Katuri V; Dillner A; Mishra B; Deng CX; Mishra L
Science; 2003 Jan; 299(5606):574-7. PubMed ID: 12543979
[TBL] [Abstract][Full Text] [Related]
7. RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF.
Saha T; Vardhini D; Tang Y; Katuri V; Jogunoori W; Volpe EA; Haines D; Sidawy A; Zhou X; Gallicano I; Schlegel R; Mishra B; Mishra L
Oncogene; 2006 Feb; 25(5):693-705. PubMed ID: 16247473
[TBL] [Abstract][Full Text] [Related]
8. Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice.
Redman RS; Katuri V; Tang Y; Dillner A; Mishra B; Mishra L
J Oral Pathol Med; 2005 Jan; 34(1):23-9. PubMed ID: 15610403
[TBL] [Abstract][Full Text] [Related]
9. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF.
Kim SS; Shetty K; Katuri V; Kitisin K; Baek HJ; Tang Y; Marshall B; Johnson L; Mishra B; Mishra L
Biochem Biophys Res Commun; 2006 Jun; 344(4):1216-23. PubMed ID: 16650383
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of TGF-beta signaling in lung cancer results in increased CDK4 activity that can be rescued by ELF.
Baek HJ; Kim SS; da Silva FM; Volpe EA; Evans S; Mishra B; Mishra L; Marshall MB
Biochem Biophys Res Commun; 2006 Aug; 346(4):1150-7. PubMed ID: 16782056
[TBL] [Abstract][Full Text] [Related]
12. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
13. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
Chen F; Zhuang M; Peng J; Wang X; Huang T; Li S; Lin M; Lin H; Xu Y; Li J; Chen Z; Huang Y
Mol Med Rep; 2014 Oct; 10(4):1999-2003. PubMed ID: 25109410
[TBL] [Abstract][Full Text] [Related]
14. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
[TBL] [Abstract][Full Text] [Related]
15. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
16. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
Osman A; Niles EG; LoVerde PT
J Biol Chem; 2004 Feb; 279(8):6474-86. PubMed ID: 14630909
[TBL] [Abstract][Full Text] [Related]
17. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells.
Liu L; Santora R; Rao JN; Guo X; Zou T; Zhang HM; Turner DJ; Wang JY
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1056-67. PubMed ID: 12855402
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
19. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line.
Lee S; Cho YS; Shim C; Kim J; Choi J; Oh S; Kim J; Zhang W; Lee J
Int J Cancer; 2001 Nov; 94(4):500-7. PubMed ID: 11745435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]